{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:51:39Z","timestamp":1792158699907,"version":"4.4.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acne recurrence after oral isotretinoin remains common, but the clinical, treatment-related, hormonal, and metabolic factors associated with recurrence are not well defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 351 patients (185 males and 166 females) with severe acne who received oral isotretinoin treatment between April 2021 and April 2025. Patients were classified into recurrence and non-recurrence groups according to follow-up outcomes after isotretinoin discontinuation. Baseline demographic characteristics, acne-related clinical features, isotretinoin treatment variables, peripheral sex hormone profiles, and metabolic parameters were collected. Univariate and multivariable logistic regression analyses were used to identify factors associated with recurrence. The combined prediction model was derived from the final multivariable logistic regression model and subsequently evaluated using receiver operating characteristic curve analysis, calibration assessment, and bootstrap internal validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 20.0 months, 91 patients developed recurrence, with an overall recurrence rate of 25.9%. Multivariate analysis showed that longer disease duration, lower cumulative isotretinoin dose, higher free androgen index, higher dehydroepiandrosterone sulfate, lower sex hormone-binding globulin, higher homeostatic model assessment of insulin resistance, higher triglyceride levels, and lower high-density lipoprotein cholesterol were independently associated with recurrence. Individual hormonal and metabolic indicators showed limited discriminatory ability. The combined prediction model demonstrated better performance, with an area under the curve of 0.824, sensitivity of 76.9%, and specificity of 76.2%. Bootstrap internal validation yielded a corrected area under the curve of 0.812.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Individual hormonal and metabolic markers had limited discriminatory value, whereas a combined model integrating disease duration, cumulative isotretinoin dose, free androgen index, dehydroepiandrosterone sulfate, sex hormone-binding globulin, HOMA-IR, triglycerides, and high-density lipoprotein cholesterol showed better internal performance. Because cumulative dose becomes available during treatment, the model is best regarded as an exploratory dynamic risk-stratification tool; external prospective validation and a clearly defined management pathway are required before routine clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1912708","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:38:11Z","timestamp":1789360691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of baseline peripheral sex hormone profiles and metabolic parameters with recurrence after oral isotretinoin treatment in patients with severe acne"],"prefix":"10.3389","volume":"17","author":[{"given":"Li-Fen","family":"Song","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Traditional Chinese Medicine)","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Urology, Dongguan Hospital of Traditional Chinese Medicine","place":["Dongguan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Dongguan Hospital of Traditional Chinese Medicine","place":["Dongguan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2296855","article-title":"The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management","volume":"35","author":"Del Rosso","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.12659\/msm.945336","article-title":"Skin barrier dysfunction in acne vulgaris: Pathogenesis and therapeutic approaches","volume":"30","author":"Deng","year":"2024","journal-title":"Med Sci Monit"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.3390\/jcm14186473","article-title":"Isotretinoin treatment for acne vulgaris: A five-year retrospective analysis of clinical and biochemical adverse effects","volume":"14","author":"Feszak","year":"2025","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2024.07.008","article-title":"The Mayo Clinic experience: Once daily dosing of isotretinoin for acne","volume":"17","author":"Maredia","year":"2024","journal-title":"JAAD Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70331","article-title":"Update of the EuroGuiDerm evidence-based guideline for the treatment of acne-short version","author":"Nast","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/cells14100747","article-title":"The sebaceous gland: A key player in the balance between homeostasis and inflammatory skin diseases","volume":"14","author":"Mosca","year":"2025","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","first-page":"29342","DOI":"10.1038\/s41598-025-12344-5","article-title":"Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients","volume":"15","author":"Rao","year":"2025","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5336","article-title":"Evaluation of the relationship between insulin resistance and visceral adiposity index in patients with acne vulgaris","volume":"52","author":"Kaya","year":"2022","journal-title":"Turk J Med Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-026-01681-6","article-title":"Expert consensus on the rational approach to isotretinoin usage for effective management of acne: ERAISE ACNE recommendations","author":"Kandhari","year":"2026","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.5416","article-title":"Acne relapse and isotretinoin retrial in patients with acne","volume":"161","author":"Lai","year":"2025","journal-title":"JAMA Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25785478261438102","DOI":"10.1177\/25785478261438102","article-title":"Phototherapy for acne vulgaris: Strategies and clinical applications in sebum modulation, inflammation control, and scar management","volume":"51","author":"Ren","year":"2026","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/25785478261438102","article-title":"Etiology of adult female acne-systematic review","volume":"8","author":"Telkk\u00e4l\u00e4","year":"2025","journal-title":"Health Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72886","article-title":"Effect of a low-glycemic-load diet and dietary counseling on acne vulgaris severity among female patients aged 15 to 35 years","volume":"16","author":"Raza","year":"2024","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70497","article-title":"Evaluation of the efficacy of metformin in the treatment of acne vulgaris and its effects on serum lipid metabolism","volume":"24","author":"Hu","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.14017","article-title":"The association of glucose metabolism disorders and acne in women with polycystic ovary syndrome (PCOS)","volume":"39","author":"Damoulaki","year":"2025","journal-title":"In Vivo"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/met.2022.0073","article-title":"Prevalence of metabolic syndrome and insulin resistance in adult patients with acne: Association with traditional cardiovascular risk factors and acne severity","volume":"21","author":"Carneiro","year":"2023","journal-title":"Metab Syndr Relat Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/met.2022.0073","article-title":"Relationship between the triglyceride\/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome","volume":"56","author":"Roa Barrios","year":"2009","journal-title":"Endocrinol Nutr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15162018","article-title":"Acne vulgaris associated with metabolic syndrome: A three-case series highlighting pathophysiological links and therapeutic challenges","volume":"15","author":"Endres","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1538373","article-title":"Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: A mini review","volume":"11","author":"Wu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"Bmj"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: A step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"Bmj"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05409.x","article-title":"High-dose isotretinoin in acne vulgaris: Improved treatment outcomes and quality of life","volume":"51","author":"Cyrulnik","year":"2012","journal-title":"Int J Dermatol"}],"updated-by":[{"DOI":"10.3389\/fendo.2026.2005509","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1912708\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:02:58Z","timestamp":1792155778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1912708\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":22,"alternative-id":["10.3389\/fendo.2026.1912708"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1912708","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1912708"}}